“does the new critical covid patient trial have a placebo arm?”

I’m assuming so, although it doesn’t clarify in the PR and I didn’t listen to the YouTube video. Without a placebo arm, it would be hard to compare length of hospital stay in leronlimab vs current SOC. SOC data from another critical trial could be used for comparison, but SOC has advanced over the past months so historical SOC data may be inaccurate. We’ll probably find out soon as the protocol will hopefully be approved this week.